Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma plc

16 Nov 2005 11:35

Aviva PLC16 November 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) AVIVA PLC AND ITS SUBISIDIARIESCompany dealt in SKYEPHARMA PLCClass of relevant security to which the ORD GBP0.10dealings being disclosed relate (Note 2)Date of dealing 15 NOVEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 35,852,550 4.756% 0 0%(2) Derivatives (other than options) 0% 0%(3) Options and agreements to purchase/sell 0% 0%Total 35,852,550 4.756% 0 0% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities 0% 0%(2) Derivatives (other than options) 0% 0%(3) Options and agreements to purchase/sell 0% 0%Total 0% 0% (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) PURCHASE 1,700,000 GBP0.504412 (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name,e.g. Writing, Number of Exercise Type, e.g. Expiry Option moneypaidcall option selling, securities to which price American, date /received per purchasing, the option relates European etc. unit (Note 5) varying etc. (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 16 NOVEMBER 2005Contact name NEIL WHITTAKERTelephone number 01603 684420If a connected EFM, name of offeree/offeror with which N/AconnectedIf a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Sep 20114:10 pmRNSSkyePharma: NDA submission in US for Lodotra in RA
12th Sep 201112:00 pmRNSHolding(s) in Company
9th Sep 20112:15 pmRNSHolding(s) in Company
7th Sep 20115:15 pmRNSDirector/PDMR Shareholding
7th Sep 20117:00 amRNSHead of Sales and Business Development Appointed
2nd Sep 20111:10 pmRNSUpdate on Diabetes Product Candidate
18th Aug 20117:00 amRNSHalf Yearly Report
17th Aug 20117:00 amRNSRe Agreement
8th Aug 20114:37 pmRNSDirector/PDMR Shareholding
8th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 201111:18 amRNSHolding(s) in Company
3rd Aug 20117:00 amRNSNotice of Results
1st Aug 20117:00 amRNSAmendment to CRC Finance Facility
1st Aug 20117:00 amRNSRe Alliance with the Aenova Group
28th Jul 20117:00 amRNSRe Agreement
12th Jul 20114:41 pmRNSSecond Price Monitoring Extn
12th Jul 20114:35 pmRNSPrice Monitoring Extension
8th Jul 20114:35 pmRNSPrice Monitoring Extension
7th Jul 20112:52 pmRNSDirector/PDMR Shareholding
24th Jun 20114:35 pmRNSPrice Monitoring Extension
23rd Jun 20114:35 pmRNSPrice Monitoring Extension
21st Jun 20114:40 pmRNSSecond Price Monitoring Extn
21st Jun 20114:35 pmRNSPrice Monitoring Extension
6th Jun 20115:06 pmRNSDirector/PDMR Shareholding
1st Jun 20114:40 pmRNSSecond Price Monitoring Extn
1st Jun 20114:35 pmRNSPrice Monitoring Extension
24th May 20114:40 pmRNSSecond Price Monitoring Extn
24th May 20114:35 pmRNSPrice Monitoring Extension
23rd May 20114:40 pmRNSSecond Price Monitoring Extn
23rd May 20114:36 pmRNSPrice Monitoring Extension
20th May 201111:20 amRNSDirector/PDMR Shareholding
19th May 20114:35 pmRNSPrice Monitoring Extension
13th May 20114:40 pmRNSSecond Price Monitoring Extn
13th May 20114:35 pmRNSPrice Monitoring Extension
12th May 201112:28 pmRNSAGM Results
12th May 20117:00 amRNSInterim Management Statement
10th May 20114:41 pmRNSSecond Price Monitoring Extn
10th May 20114:35 pmRNSPrice Monitoring Extension
6th May 20114:40 pmRNSSecond Price Monitoring Extn
6th May 20114:35 pmRNSPrice Monitoring Extension
5th May 20114:40 pmRNSSecond Price Monitoring Extn
5th May 20114:35 pmRNSPrice Monitoring Extension
4th May 20114:35 pmRNSPrice Monitoring Extension
3rd May 20114:35 pmRNSPrice Monitoring Extension
27th Apr 20114:40 pmRNSSecond Price Monitoring Extn
27th Apr 20114:35 pmRNSPrice Monitoring Extension
26th Apr 20114:35 pmRNSPrice Monitoring Extension
26th Apr 20113:47 pmRNSAnnual Information Update
11th Apr 20115:10 pmRNSDirector/PDMR Shareholding
7th Apr 20113:26 pmRNSAnnual Report and Accounts 2010

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.